Citadel Advisors’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.38M Sell
41,291
-103,643
-72% -$11.8M ﹤0.01% 4558
2025
Q4
$15.4M Buy
144,934
+54,948
+61% +$5.55M ﹤0.01% 2673
2025
Q3
$8.43M Buy
89,986
+47,608
+112% +$4.43M ﹤0.01% 3513
2025
Q2
$3.67M Buy
42,378
+8,454
+25% +$707K ﹤0.01% 4632
2025
Q1
$2.62M Sell
33,924
-21,386
-39% -$1.96M ﹤0.01% 5018
2024
Q4
$5.35M Buy
55,310
+11,025
+25% +$1.11M ﹤0.01% 3851
2024
Q3
$4.2M Buy
44,285
+19,096
+76% +$1.67M ﹤0.01% 4234
2024
Q2
$2.1M Buy
25,189
+24,504
+3,577% +$2.04M ﹤0.01% 5209
2024
Q1
$58.8K Sell
685
-3,837
-85% -$312K ﹤0.01% 12019
2023
Q4
$374K Sell
4,522
-45,277
-91% -$3.32M ﹤0.01% 8702
2023
Q3
$3.58M Sell
49,799
-32,514
-40% -$2.47M ﹤0.01% 4186
2023
Q2
$6.24M Buy
82,313
+70,423
+592% +$4.74M ﹤0.01% 3309
2023
Q1
$750K Sell
11,890
-4,077
-26% -$239K ﹤0.01% 7411
2022
Q4
$868K Sell
15,967
-1,104
-6% -$65.6K ﹤0.01% 7077
2022
Q3
$976K Buy
+17,071
New +$946K ﹤0.01% 7045
2022
Q2
Sell
-25,786
Closed -$1.35M 12758
2022
Q1
$1.48M Sell
25,786
-5,162
-17% -$266K ﹤0.01% 6758
2021
Q4
$1.63M Sell
30,948
-45,327
-59% -$2.42M ﹤0.01% 6705
2021
Q3
$3.83M Buy
76,275
+58,771
+336% +$3.05M ﹤0.01% 4842
2021
Q2
$1.03M Sell
17,504
-23,540
-57% -$1.46M ﹤0.01% 8300
2021
Q1
$2.67M Buy
41,044
+10,417
+34% +$640K ﹤0.01% 5725
2020
Q4
$1.68M Buy
30,627
+21,074
+221% +$1.08M ﹤0.01% 5733
2020
Q3
$421K Sell
9,553
-42,101
-82% -$1.85M ﹤0.01% 7569
2020
Q2
$2.18M Buy
+51,654
New +$1.99M ﹤0.01% 4411
2020
Q1
Sell
-418,459
Closed -$17.7M 9520
2019
Q4
$18.6M Sell
418,459
-98,365
-19% -$3.78M 0.01% 1552
2019
Q3
$17.7M Buy
516,824
+265,135
+105% +$9.18M 0.01% 1594
2019
Q2
$9.47M Sell
251,689
-103,784
-29% -$3.55M ﹤0.01% 2241
2019
Q1
$10.9M Buy
355,473
+47,775
+16% +$1.46M 0.01% 1965
2018
Q4
$8.52M Buy
+307,698
New +$8.45M ﹤0.01% 2098

Other funds holding ACA

Citadel Advisors's ACA Position: Q1 2026 in Review

Citadel Advisors reduced its Arcosa (ACA) stake by 72% in Q1 2026, selling an estimated $11.8M and leaving 41,291 shares worth $4.38M. The position accounts for ﹤0.01% of the portfolio, ranked #4558.

Citadel Advisors first reported a position in ACA in Q4 2018 and has held it in 28 quarters since. The position peaked at $18.6M in Q4 2019. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • Citadel Advisors held 41,291 shares of Arcosa worth $4.38M as of Q1 2026.
  • Citadel Advisors sold 103,643 Arcosa shares in Q1 2026, an estimated $11.8M.
  • Arcosa made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4558 holding.
  • Citadel Advisors first reported a position in Arcosa in Q4 2018 and has held it in 28 quarters since.
  • Citadel Advisors's Arcosa position peaked at $18.6M in Q4 2019.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.